2-hydroxycycloalkane-1-carbamoyl derivatives

The present invention relates to compounds of Formula (I) wherein Ar1, Ar2, L, n, and R1 are as described in the description, their preparation, to pharmaceutically acceptable salts thereof, and to their use as pharmaceuticals, to pharmaceutical compositions containing one or more compounds of Formu...

Full description

Saved in:
Bibliographic Details
Main Authors SAGER, CHRISTOPH, REMEN, LUBOS, BOLLI, MARTIN, ZUMBRUNN, CORNELIA, GRISOSTOMI, CORINNA, GATFIELD, JOHN
Format Patent
LanguageChinese
English
Published 01.09.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention relates to compounds of Formula (I) wherein Ar1, Ar2, L, n, and R1 are as described in the description, their preparation, to pharmaceutically acceptable salts thereof, and to their use as pharmaceuticals, to pharmaceutical compositions containing one or more compounds of Formula (I), and especially to their use as Galectin-3 inhibitors.
AbstractList The present invention relates to compounds of Formula (I) wherein Ar1, Ar2, L, n, and R1 are as described in the description, their preparation, to pharmaceutically acceptable salts thereof, and to their use as pharmaceuticals, to pharmaceutical compositions containing one or more compounds of Formula (I), and especially to their use as Galectin-3 inhibitors.
Author BOLLI, MARTIN
ZUMBRUNN, CORNELIA
GRISOSTOMI, CORINNA
REMEN, LUBOS
GATFIELD, JOHN
SAGER, CHRISTOPH
Author_xml – fullname: SAGER, CHRISTOPH
– fullname: REMEN, LUBOS
– fullname: BOLLI, MARTIN
– fullname: ZUMBRUNN, CORNELIA
– fullname: GRISOSTOMI, CORINNA
– fullname: GATFIELD, JOHN
BookMark eNrjYmDJy89L5WTQMdLNqEwpyq-oTK5MzslPzMlOzEvVNdRNTixKSszNr8xRSEktyixLLMksSy3mYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxIeFGBkZGxsZmBpaOxsSoAQCnxSwC
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID TW202233609A
GroupedDBID EVB
ID FETCH-epo_espacenet_TW202233609A3
IEDL.DBID EVB
IngestDate Fri Aug 16 05:56:12 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Chinese
English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_TW202233609A3
Notes Application Number: TW202110140598
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220901&DB=EPODOC&CC=TW&NR=202233609A
ParticipantIDs epo_espacenet_TW202233609A
PublicationCentury 2000
PublicationDate 20220901
PublicationDateYYYYMMDD 2022-09-01
PublicationDate_xml – month: 09
  year: 2022
  text: 20220901
  day: 01
PublicationDecade 2020
PublicationYear 2022
RelatedCompanies IDORSIA PHARMACEUTICALS LTD
RelatedCompanies_xml – name: IDORSIA PHARMACEUTICALS LTD
Score 3.5526822
Snippet The present invention relates to compounds of Formula (I) wherein Ar1, Ar2, L, n, and R1 are as described in the description, their preparation, to...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title 2-hydroxycycloalkane-1-carbamoyl derivatives
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220901&DB=EPODOC&locale=&CC=TW&NR=202233609A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMTNMSzNPTk3RNU81T9I1STZI07VISgIWhoZAvnmioYWBOWi_s6-fmUeoiVeEaQQTQxZsLwz4nNBy8OGIwByVDMzvJeDyugAxiOUCXltZrJ-UCRTKt3cLsXVRg_aOjYwMgPWbmouTrWuAv4u_s5qzs21IuJpfEFjO2NjMwNKRmYEV1IwGnbPvGuYE2pVSgFyluAkysAUATcsrEWJgqsoQZuB0ht28JszA4Qud8AYyoXmvWIRBx0g3ozIFtOokuTI5Jz8xJzsxLxXYNUsGzRjk5lfmKKQAU1MZ-CDvYlEGRTfXEGcPXaC18XA_xoeEI1xoLMbAAuz7p0owKCQlm6aA7uxKAvaMTIwMUxPNUpKSUo1NTEEtCyMzC0kGKdzmSOGTlGbgAnEgy6VkGFhKikpTZYH1a0mSHDhgALCKf8s
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR3LTsJAcIJoxJuiBvGFienJxr5o8dAYaWlQoRBThVvT3S5BRSC2aurXO7sW8aK33Z1k9pGd185jAU5NdTSyKItli1lENqgykhuEIDNUsW9FakOxeL5z1zfb98bNsD4swNMiF0bUCf0QxRGRoijSeyr49Xz5iOWK2MrknDzi0OzSC2xXyq1jTVNQvklu0271e27PkRzHDgaSfydgum4qF1crsGrx6rxcdXpo8qyU-W-R4m3CWh-xTdMtKHyOy1ByFj-vlWG9mzu8sZnTXrINZ5o8zmIedUIzOplFk-doytA0o9xj8DLLJrUYb9O7KOSd7MCJ1wqctozThj97DIPBcoX6LhTR9mcVqBFaj_mfXQQtI0NTWWTGhDDdqHPNQjMbe1D9G0_1P-AxlNpBtxN2rv3bfdjggO_QqQMopq9v7BBlbUqOxCF9AdLIgrg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=2-hydroxycycloalkane-1-carbamoyl+derivatives&rft.inventor=SAGER%2C+CHRISTOPH&rft.inventor=REMEN%2C+LUBOS&rft.inventor=BOLLI%2C+MARTIN&rft.inventor=ZUMBRUNN%2C+CORNELIA&rft.inventor=GRISOSTOMI%2C+CORINNA&rft.inventor=GATFIELD%2C+JOHN&rft.date=2022-09-01&rft.externalDBID=A&rft.externalDocID=TW202233609A